Concepedia

Aravind Ponnuswamy

AP

Statistics

Publications

4

Citations

1.3K

H-Index

4

Active since

2021

Affiliations

University College London(Current)

Royal Free London NHS Foundation Trust

Barts Health NHS Trust

Aravind Ponnuswamy is an author at University College London specializing in pharmacotherapy, primary outcome analysis, and open-label trials.

Publications per year

2021–2024

4

Publications

4

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi et al. · The Lancet · 2021 · 564 citations · Full text

, , +6

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text

, , +14

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text

, , +13

Non-tuberculous mycobacterial pulmonary disease (NTM-PD): Epidemiology, diagnosis and multidisciplinary management

Kartik Kumar, Aravind Ponnuswamy, Toby Capstick et al. · Clinical Medicine · 2024 · 63 citations · Full text

, , +17

1–4 of 4